Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTH Gel in Scleritis (ATLAS)
NCT03465111Phase 2Unknown
- Sponsor
- Massachusetts Eye Research and Surgery Institute
- Start
- Jan 2019
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of repository corticotropin injection in scleritis, sponsored by Massachusetts Eye Research and Surgery Institute. Status: unknown.
02
Drugs
repository corticotropin injection
03
Conditions
scleritis
Beyond the preview
Go deeper on NCT03465111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03465111.